AzTrials
AzTrials

Medical EducationCERESNCT06759012

An Agentic Co-educator System for Personalized Medical Education

A study testing EyeTeacher in people with Medical Education, run by Tsinghua University at 7 sites in 6 countries.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

With the rise of generative artificial intelligence and large language models, medical education is undergoing a significant transformation. Numerous studies have highlighted the limitations of traditional educational knowledge acquisition and the potential impact of artificial intelligence on medical education… Read more about this study

Who is it for?
Ages 21 to 40 yearsHealthy volunteers can take part
Conditions the study is for
Medical Education
What is being tested?
EyeTeacher
Could I receive a placebo?
No, everyone receives an active treatment
How many people
269 participants
Where
7 sitesin 6 countries
Study dates
2 Mar 2025to 30 Jul 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 to 40 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Clinical medical students who have not taken ophthalmology courses
  • Age 21-40
  • Gender not restricted
  • Sign the informed consent form

Who cannot join

  • Refusal of the research protocol.
  • Participants unwilling or unable to understand and complete the questionnaire.

Trial locations and contacts

7 sites in 6 countries.

7 sites in 6 countries

China2 sites
  • Peking Union Medical College Hospital

    Beijing, Beijing Municipality, 430022

  • BenQ Medical Center, Nanjing Medical University Affiliated Hospital

    Nanjing, Jiangsu, 210019

Other trials in China

Australia1 site
  • University of Melbourne

    Melbourne, Victoria, 3010

Other trials in Australia

Ghana1 site
  • University of Ghana

    Accra, Greater Accra Region, P.O. Box LG 586

Other trials in Ghana

India1 site
  • Sankara Nethralaya

    Chennai, Tamil Nadu, 600 006

Other trials in India

Malaysia1 site
  • University of Malaya

    Kuala Lumpur, Kuala Lumpur, 50603

Other trials in Malaysia

United Kingdom1 site
  • Moorfields Eye Hospital

    London, EC1V 2PD

Other trials in United Kingdom

About this study

With the rise of generative artificial intelligence and large language models, medical education is undergoing a significant transformation. Numerous studies have highlighted the limitations of traditional educational knowledge acquisition and the potential impact of artificial intelligence on medical education, resident training, and continuing education for clinical practitioners. However, there is a lack of real-world experiments on the effectiveness of AI-integrated education.

Artificial intelligence can provide extensive educational resources and tools that are not limited by geographical location or language, thereby lowering the barrier to accessing high-quality medical education and promoting educational equity. Nevertheless, the performance of AI models trained by different medical institutions or healthcare systems may vary.

To offer a more universal, accessible, high-quality, and interconnected educational journey. We have developed a virtual ophthalmology teacher, which developed based on foundational model and large language models. This model, named EyeTeacher provide comprehensive theoretical knowledge and clinical skills enhancement for untrained medical students. To verify the effectiveness of our EyeTeacher across different national ophthalmology education systems and languages, we plan to implement a randomized controlled trial. This trial will assess the clinical capabilities of all participants and explore the advantages and disadvantages of the system compared to traditional teaching methods.

Being tested
EyeTeacher
Keywords
Medical education, Multimodality AI, Generative AI

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • EyeTeacherOther

    Participants randomized to the intervention group will receive access to the EyeTeacher system, along with their username, password, and a user manual, one week before the start of the course. They will follow instructions on the website and complete a quiz before and after each course. After completing the EyeTeacher curriculum, they will take the first examination (Examination 1) and complete a set of questionnaires. A classroom will be provided for study purposes, but no restrictions will be imposed on the study location. Following the EyeTeacher section, participants will attend the ophthalmology course in the regular training program, with support from the EyeTeacher system. They will be evaluated according to the ophthalmology posting's evaluation criteria (Examination 2).

Study groups in NCT06759012
Study groupRoleWhat they receive
Interventional groupExperimentalAttend EyeTeacher lecture before taking the regular ophthalmology lecture in medical school.
Receives: Other: EyeTeacher
Control groupNo interventionAttend regular ophthalmology lectures in medical school.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Grade of ophthalmology examination

    Title: Ophthalmology Theoretical Examination. The examination includes 40 multiple-choice questions and two essay questions related to ophthalmology knowledge, to be completed within one hour without the use of reference materials. The exam will be graded by experts based on a standardized answer key. The score ranges from 0 to 100, with a higher score indicating a deeper understanding of the ophthalmology knowledge.

    Students in both the interventional group and the control group will complete the exam within the specified time on the EyeTeacher system. The data will be collected in the system's backend.

    Measured: 1 day after complete lectures

Secondary outcomes (2)
  1. Time of studying ophthalmology

    The study time spent using each teaching module in the interventional group is tracked by the EyeTeacher system website, while the study time for the control group and the out-of-system study time for the interventional group are collected through a questionnaire.

    Questionnaire title: Time of Study in Ophthalmology The questionnaire consists of fill-in-the-blank questions, with time measured in minutes. The content includes: class time, exercise time, discussion time, and reading reference material time. The questionnaires for both the interventional and control groups are completed on the EyeTeacher system, and the data is collected through the backend.

    Measured: 1 day after complete lectures

  2. Feedback of teaching from students

    Questionnaire title: Feedback of Study in Ophthalmology:

    The Likert scale is used for scoring. The topics include students' evaluations of course design, teacher guidance, empathy, as well as students' self-assessment and evaluation of their interest in ophthalmology.

    The questionnaires for both the interventional and control groups are completed on the EyeTeacher system, and the data is collected through the backend.

    Measured: 1 day after complete lectures

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2025
  2. Study start2 Mar 2025
  3. Primary completion15 Jun 2026
  4. Study completion30 Jul 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
269 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06759012
Sponsor's protocol ID
THU01-20240100
Acronym
CERES
Status last verified
Aug 2026
First submitted
5 Dec 2024
Last updated
19 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • He B, Kwan AC, Cho JH, Yuan N, Pollick C, Shiota T, Ebinger J, Bello NA, Wei J, Josan K, Duffy G, Jujjavarapu M, Siegel R, Cheng S, Zou JY, Ouyang D. Blinded, randomized trial of sonographer versus AI cardiac function assessment. Nature. 2023 Apr;616(7957):520-524. doi: 10.1038/s41586-023-05947-3. Epub 2023 Apr 5.

    PubMed 37020027
  • Benitez TM, Xu Y, Boudreau JD, Kow AWC, Bello F, Van Phuoc L, Wang X, Sun X, Leung GK, Lan Y, Wang Y, Cheng D, Tham YC, Wong TY, Chung KC. Harnessing the potential of large language models in medical education: promise and pitfalls. J Am Med Inform Assoc. 2024 Feb 16;31(3):776-783. doi: 10.1093/jamia/ocad252.

    PubMed 38269644

Questions about this trial

What is this clinical trial studying?

A study testing EyeTeacher in people with Medical Education, run by Tsinghua University at 7 sites in 6 countries.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 7 sites in China, Australia, Ghana, India, Malaysia and 1 more country. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Grade of ophthalmology examination (time frame: 1 day after complete lectures). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06759012, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in